Cognitive and Motor Functionality in Parkinson's Disease
Summary
Parkinson’s disease is characterised by the progressive degeneration of dopaminergic neurons within the substantia nigra, leading to hallmark motor disturbances such as bradykinesia, rigidity and postural instability. In parallel, a substantial proportion of patients experience cognitive changes that range from subtle executive dysfunction to frank dementia. Motor and cognitive domains interact through distributed neural networks: basal ganglia circuits that support automatic movement also modulate aspects of planning, attention and working memory. As the disease advances, compensatory mechanisms in cortical and cerebellar regions are recruited to sustain performance. Individual differences in life-long experiences and structural brain reserves further shape clinical trajectories, with some patients exhibiting slower decline owing to greater cognitive or motor reserve. Modern neuroimaging and neurophysiological techniques have illuminated how alterations in network connectivity, synaptic plasticity and neurotransmitter dynamics underpin both symptom emergence and compensation. Understanding these processes is vital for optimising symptomatic therapies, designing personalised rehabilitation programmes and identifying novel targets to preserve function.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Cognitive and Motor Functionality in Parkinson's Disease publication trend
The graph below shows the total number of articles in cognitive and motor functionality in parkinson's disease across all publications each year (not limited to Nature Index journals).
Technical terms
Basal ganglia: Subcortical nuclei integral to motor control, action selection and procedural learning.
Bradykinesia: Slowness of voluntary movement, one of the cardinal motor features of Parkinson’s disease.
Cognitive reserve: The brain’s resilience to neuropathological damage, influenced by life-long intellectual and social engagement.
Motor reserve: The capacity of the motor system to maintain performance despite neurodegenerative changes.
Dopamine transporter imaging (DaT): A neuroimaging technique that quantifies presynaptic dopamine transporter availability as a marker of nigrostriatal integrity.
References
- Clinical severity in Parkinson’s disease is determined by decline in cortical compensation. Brain (2023).
- Influence of cognitive reserve on cognitive and motor function in α-synucleinopathies: A systematic review and multilevel meta-analysis. Neuroscience & Biobehavioral Reviews (2024).
- Local striatal volume and motor reserve in drug-naïve Parkinson’s disease. npj Parkinson's Disease (2022).
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.